218 related articles for article (PubMed ID: 24636042)
1. Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
Brookshire HL; English RV; Nadelstein B; Weigt AK; Gift BW; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):175-85. PubMed ID: 24636042
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
[TBL] [Abstract][Full Text] [Related]
3. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
[TBL] [Abstract][Full Text] [Related]
4. Comparison of capsular opacification and refractive status after placement of three different intraocular lens implants following phacoemulsification and aspiration of cataracts in dogs.
Gift BW; English RV; Nadelstein B; Weigt AK; Gilger BC
Vet Ophthalmol; 2009; 12(1):13-21. PubMed ID: 19152593
[TBL] [Abstract][Full Text] [Related]
5. Comparison of posterior capsule opacification between the 1-piece and 3-piece Acrysof intraocular lenses: two-year results of a randomized trial.
Sacu S; Findl O; Menapace R; Buehl W; Wirtitsch M
Ophthalmology; 2004 Oct; 111(10):1840-6. PubMed ID: 15465544
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Waterbury LD; Silliman D; Jolas T
Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of sharp optic edges of a polymethyl methacrylate intraocular lens on posterior capsule opacification: a randomized trial.
Findl O; Buehl W; Menapace R; Sacu S; Georgopoulos M; Rainer G
Ophthalmology; 2005 Nov; 112(11):2004-8. PubMed ID: 16168485
[TBL] [Abstract][Full Text] [Related]
8. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Lane SS; Holland EJ
J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
[TBL] [Abstract][Full Text] [Related]
9. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
[TBL] [Abstract][Full Text] [Related]
10. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of 1-piece and 3-piece hydrophobic acrylic intraocular lens on posterior capsule opacification: a randomized trial.
Leydolt C; Davidovic S; Sacu S; Menapace R; Neumayer T; Prinz A; Buehl W; Findl O
Ophthalmology; 2007 Sep; 114(9):1663-9. PubMed ID: 17822973
[TBL] [Abstract][Full Text] [Related]
12. Effect of optic material on posterior capsule opacification in intraocular lenses with sharp-edge optics: randomized clinical trial.
Findl O; Menapace R; Sacu S; Buehl W; Rainer G
Ophthalmology; 2005 Jan; 112(1):67-72. PubMed ID: 15629822
[TBL] [Abstract][Full Text] [Related]
13. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
Walters TR; Goldberg DF; Peace JH; Gow JA;
Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
Mukai K; Matsushima H; Gotoh N; Aose M; Satoshi W; Wataru T; Matsui E; Nagata M; Senoo T
J Cataract Refract Surg; 2009 Sep; 35(9):1614-8. PubMed ID: 19683162
[TBL] [Abstract][Full Text] [Related]
15. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L
Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510
[TBL] [Abstract][Full Text] [Related]
16. Effects of one-week versus one-day preoperative treatment with topical 1% prednisolone acetate in dogs undergoing phacoemulsification.
McLean NJ; Ward DA; Hendrix DV; Vaughn RK
J Am Vet Med Assoc; 2012 Mar; 240(5):563-9. PubMed ID: 22332625
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of adding a sharp posterior optic edge to a three-piece silicone intraocular lens on capsule opacification: five-year results of a randomized study.
Sacu S; Menapace R; Findl O; Kiss B; Buehl W; Georgopoulos M
Am J Ophthalmol; 2005 Apr; 139(4):696-703. PubMed ID: 15808167
[TBL] [Abstract][Full Text] [Related]
18. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
Durrie DS; Kennard MG; Boghossian AJ
Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.
Walter KA; Lee RY; Chen K; Komanski C
Arq Bras Oftalmol; 2020; 83(1):55-61. PubMed ID: 31664337
[TBL] [Abstract][Full Text] [Related]
20. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
